Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for 908 Devices Inc. despite lower revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - The upcoming earnings report is expected to show a quarterly loss of $0.13 per share, reflecting a year-over-year change of +43.5%, while revenues are projected at $13.58 million, down 19% from the previous year [3]. - A positive stock movement is likely if key numbers exceed expectations, whereas missing estimates may lead to a decline [2]. Estimate Revisions - The consensus EPS estimate has been revised 6.25% lower in the last 30 days, indicating a bearish sentiment among analysts regarding the company's earnings prospects [4][12]. - The Most Accurate Estimate is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -18.42%, complicating predictions for an earnings beat [12]. Earnings Surprise History - In the last reported quarter, 908 Devices was expected to post a loss of $0.16 per share but actually reported a loss of $0.18, resulting in a surprise of -12.50% [13]. - Over the past four quarters, the company has beaten consensus EPS estimates three times [14]. Industry Context - In the Zacks Medical - Instruments industry, Mettler-Toledo is expected to report earnings of $10.62 per share, indicating a year-over-year change of +4%, with revenues projected at $991.67 million, up 3.9% [18][19]. - Mettler-Toledo's consensus EPS estimate has been revised 0.5% lower, leading to an Earnings ESP of -0.42%, making it difficult to predict an earnings beat [19][20].
Will 908 Devices Inc. (MASS) Report Negative Earnings Next Week? What You Should Know